24R,25-Dihydroxyvitamin D3 ameliorates the high-turnover bone diseases without suppressing parathyroid function in chronic renal failure in rats

Nephrology

Volumn 2, Issue 5, 1996, Pages 361-366

  Kazama, Junichiro J ^a   Fukagawa, Masafumi ^b,d   Yi, Hung ^b   Kumagai, Miki ^c   Yamato, Hideyuki ^c   Taniguchi, Nobuyuki ^c   Gejyo, Fumitake ^a   Arakawa, Masaaki ^a   Ozawa, Hidehiro ^a   Kurokawa, Kiyoshi ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KUREHA CORPORATION   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

1,25 dihydroxyvitamin D3; 24R,25 dihydroxyvitamin D3; Bone; Chronic renal failure; Parathyroid; Parathyroid hormone

Indexed keywords

EID: 1842583376     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1996.tb00114.x     Document Type: Article

References (28)

1. Malluche H, Faugere MC. Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int. 1990; 38: 193-211.
2. Coburn JW, Llach F. Renal osteodystrophy. In: Narins RG (ed.) Clinical Disorders of Fluid and Electrolyte Metabolism, 5th ed., New York: McGraw Hill, 1994; 1299-377.
3. Slatopolsky E, Weerts C, Thielan J et al. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J. Clin. Invest. 1984; 74: 2136-43.
4. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N. Engl. J. Med. 1989; 321: 274-9.
5. Goodman WD, Ramirez JA, Belin TR et al. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int. 1994; 46: 1160-6.
6. 3 alone or in combination. Miner. Electrolyte Metab. 1985; 11: 358-68.
7. 3 therapy for bone disease in dialysis patients. Bone 1992; 13: 369-77.
8. Fukagawa M, Kaname S, Igarashi T et al. Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int. 1991; 39: 874-81.
9. Parfitt AM, Drezner MK, Glorieux FH et al. Bone histomorphometry nomenclature, symbols and units. Report of the ASBMR Histomorphomerry Nomenclature Committee. J. Bone Miner. Res. 1987; 5: 595-610.
10. Fukayawa M, Kitaoka M, Yi H et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994; 68: 221-8.
11. Ornoy A, Goodwin D, Noff D, Edelstein S. 24,25-Dihydroxy-vitamin D is a metabolite of vitamin D essential for bone formation. Nature 1978; 276: 517-19.
12. 3 metabolites and PTH synergistically stimulate bone formation of chick embryo femur in vitro. Nature 1980; 286: 262-4.
13. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J. Clin. Invest. 1986; 78: 1296-1301.
14. 3 on PTH levels and bone histology in dogs with chronic uremia. Kidney Int. 1984; 25: 791-7.
15. Henry HL. Vitamin D hydroxylases. J. Cell Biol. 1992; 49: 4-9.
16. 3. Calcif. Tissue Int. 1988; 43: 235-43.
17. 3 in the hypophostatemic mouse. J. Bone Miner. Res. 1994; 9: 1967-74.
18. 3 in dialysis osteomalacia. Am. J. Med. 1983; 74: 407-14.
19. 3 suppresses the serum parathyroid hormone levels of dialysis patients. Nephron 1991; 58: 283-7.
20. Varghese Z, Moorhead JF, Farrington K. Effect of 24,25-dihydroxycholecalciferol on intestinal absorption of calcium and phosphate and on parathyroid hormone secretion in chronic renal failure. Nephron 1992; 60: 286-91.
21. 3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone. J. Bone Miner. Res. 1995; 10: 197-204.
22. 3 ameliorates renal osteodystrophy in rats with chronic renal failure. Kidney Int. 1989; 35: 379.
23. 3 in combination with calcitriol reverses osteoclastic hyperactivity in chronic renal failure. Kidney Int. 1990; 37: 451.
24. Tsukamoto Y, Moriya R, Nomura Y et al. Long-term effect of oral calcitriol pulse therapy on bone in hemodialysis patients. Bone 1993; 14: 421-6.
25. Kazama JJ, Gejyo F, Ejiri S et al. Application of confocal laser scanning microscopy to the observation of bone biopsy specimens. Bone 1993; 14: 885-9.
26. Frost HM. A new direction for osteoporosis research: A review and proposal. Bone 1991; 12: 429-37.
27. 3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients. Bone 1993; 14: 125-31.
28. 3 on the formation and function of osteoclastic cells. Calcif. Tissue Int. 1993; 52: 225-60.